UMIN-CTR Clinical Trial
| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000026131 |
| Receipt No. | R000030025 |
| Scientific Title | Survey on the status of integrated medical care provision in Japanese medical institution |
| Date of disclosure of the study information | 2017/02/16 |
| Last modified on | 2020/08/02 (Ver. 6) |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
| Basic information | ||
| Public title | Survey on the status of integrated medical care provision in Japanese medical institution | |
| Acronym | Survey on integrated medical care provision | |
| Scientific Title | Survey on the status of integrated medical care provision in Japanese medical institution | |
| Scientific Title:Acronym | Survey on integrated medical care provision | |
| Region |
|
|
| Condition | ||
| Condition | General population | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To clarify the current state of integrated medical care at medical institutions |
| Basic objectives2 | Others |
| Basic objectives -Others | utilization study |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Actual utilization |
| Key secondary outcomes | |
| Base | |
| Study type | Others,meta-analysis etc |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Hospital director | |||
| Key exclusion criteria | None | |||
| Target sample size | 400 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Nihon Pharmaceutical University | ||||||
| Division name | Kampo Pharmaceutical Sciences | ||||||
| Zip code | 362-0806 | ||||||
| Address | 10281, Komuro, Ina, Kitaadachi, Saitama | ||||||
| TEL | 048-721-1155 | ||||||
| ichiro.arai@nichiyaku.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Nihon Pharmaceutical University | ||||||
| Division name | Kampo Pharmaceutical Sciences | ||||||
| Zip code | 362-0806 | ||||||
| Address | 10281, Komuro, Ina, Kitaadachi, Saitama | ||||||
| TEL | 048-721-1155 | ||||||
| Homepage URL | |||||||
| ichiro.arai@nichiyaku.ac.jp | |||||||
| Sponsor | |
| Institute | Nihon Pharmaceutical University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | AMED |
| Organization | |
| Division | |
| Category of Funding Organization | Japanese Governmental office |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | Kanazawa Medical University
National Institute of Public Health |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Ethics Committee, Nihon Pharmaceutical University |
| Address | 10281, Komuro, Ina, Kitaadachi, Saitama, Japan |
| Tel | +81-48-721-1155 |
| i-arai@nichiyaku.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | https://www.sciencedirect.com/science/article/pii/S221342202030086X |
| Publication of results | Published |
| Result | |||||||
| URL related to results and publications | https://www.sciencedirect.com/science/article/pii/S221342202030086X | ||||||
| Number of participants that the trial has enrolled | 231 | ||||||
| Results | The present study aimed to understand the attitudes of Japanese physicians towards integrative medicine. The internet survey on 231 physicians showed that 35% of physicians used (or advised on) TCIM in clinical practice. Prescribed Kampo medicines (87.8%) and dietary supplements (24.7%) were common. |
||||||
| Results date posted |
|
||||||
| Results Delayed | |||||||
| Results Delay Reason | |||||||
| Date of the first journal publication of results | |||||||
| Baseline Characteristics | Japanese Physicians |
||||||
| Participant flow | An e-mail request was sent to 2,395 physicians. 231 physicians respoded. |
||||||
| Adverse events | None |
||||||
| Outcome measures | Japanese version of the I-CAM-Q (I-CAM-QJ) |
||||||
| Plan to share IPD | |||||||
| IPD sharing Plan description | |||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Other | |
| Other related information | Internet survey |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030025 |
